# Study to Determine Pharmacodynamic Effects and Pharmacokinetics of KUC 7483 CL in Patients With Spinal Cord Injury and Neurogenic Detrusor Overactivity

> **NCT02259751** · PHASE1 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 26 (actual)

## Conditions studied

- Spinal Cord Injuries

## Interventions

- **DRUG:** KUC 7483 CL
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02259751
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-02
- **Primary completion:** 2005-02
- **Final completion:** —
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2014-10-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02259751

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02259751, "Study to Determine Pharmacodynamic Effects and Pharmacokinetics of KUC 7483 CL in Patients With Spinal Cord Injury and Neurogenic Detrusor Overactivity". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02259751. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*